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Pattern recognition: recent insights from Dectin-1
Delyth M Reid1, Neil AR Gow1 and Gordon D Brown1,2The b-glucan receptor Dectin-1 is an archetypical non-toll-like
pattern recognition receptor expressed predominantly by
myeloid cells, which can induce its own intracellular signalling
and can mediate a variety of cellular responses, such as
cytokine production. Recent identification of the components
of these signalling pathways, such as Syk kinase, CARD9 and
Raf-1, has provided novel insights into the molecular
mechanisms underlying Dectin-1 function. Furthermore, a
broader appreciation of the cellular responses mediated by this
receptor and the effects of interactions with other receptors,
including the TLRs, have greatly furthered our understanding of
innate immunity and how this drives the development of
adaptive immunity, particularly Th17 responses. Recent
studies have highlighted the importance of Dectin-1 in
anti-fungal immunity, in both mice and humans, and have
suggested a possible involvement of this receptor in the control
of mycobacterial infections.
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Introduction
Higher animals are equipped with a limited array of
germline encoded pattern recognition receptors (PRRs)
that recognise highly conserved microbial structures
known as pathogen associated molecular patterns
(PAMPs). Engagement of PRRs by microbes or PAMPS
directs appropriate innate immune responses and ulti-
mately the development of specific adaptive immunity
[1]. Although the toll-like receptor (TLR) family of PRRs
makes crucial contributions to extracellular pathogen
sensing and the development of immune responses, there
has been a resurgence of interest in the non-TLR PRRs,
of which the archetypical member is Dectin-1, the re-
ceptor for fungal b-glucans. The study of Dectin-1 has
Open access under CC BY license.Current Opinion in Immunology 2009, 21:30–37provided a number of new insights into the underlying
mechanisms of innate immunity [2], and here we will
review the most recent advances over the past two to
three years. We will focus primarily on ‘trends’ of parti-
cular interest, including; Dectin-1 mediated signalling
pathways, interactions of this receptor with other PRRs,
directing adaptive immunity and the role of Dectin-1 in
anti-microbial immunity.
Dectin-1: a brief overview
Dectin-1 is a glycosylated type II transmembrane re-
ceptor with a single extracellular C-type lectin-like
domain (CTLD) and a cytoplasmic immunoreceptor
tyrosine-based activation (ITAM)-like motif (also
termed a hem-ITAM), and alternative splicing results
in a number of isoforms, of which the two main func-
tional ones are depicted in Figure 1. In both humans
and mice, Dectin-1 is predominantly expressed on
myeloid cells (monocytes/macrophage, dendritic cells
and neutrophils) although limited expression has been
reported on other cells, including various populations of
lymphocytes [2].
Dectin-1 recognises b1,3-linked glucans, carbohydrates
that are found in the cell walls of plants and fungi
(Figure 1), and in some bacteria, and is the major receptor
on myeloid cells for these molecules. Ligand binding is
mediated by the CTLD and although the structure of this
domain has been solved, and functionally examined by
mutagenic analysis, the mechanism of carbohydrate
recognition is still unclear. Dectin-1 also recognises
ligand(s) onmycobacteria, and possibly some endogenous
molecules, although the physiological roles of these inter-
actions remain largely undefined [3].
Engagement of Dectin-1 on myeloid cells by b-glucans
triggers a variety of cellular responses including DC
maturation, ligand uptake by endocytosis and phagocy-
tosis, the respiratory burst, the production of arachadonic
acid metabolites and numerous cytokines and chemo-
kines, such as TNF, CXCL2, IL-23, IL-6 and IL-10 [2].
However, the ability of Dectin-1 to trigger these
responses directly is cell-type dependent, and may
require, or be enhanced by, cooperative signalling from
MyD88 coupled TLRs, as discussed below. In DCs, for
example, Dectin-1 signalling can directly induce TNF
production, yet in macrophages this response requires
additional TLR co-stimulation [4,5]. Although the
underlying reasons are not fully understood, recent evi-
dence suggests that the differences in cellular responses
result, partly, from the actions of cytokines, such as GM-
CSF and IFNg [6,7]www.sciencedirect.com
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Figure 1
Schematic representation of the fungal cell wall and downstream cellular responses following engagement of Dectin-1 and TLRs on antigen presenting
cells (APC). At the top, the interaction between the yeast cell of a fungus, such as C. albicans, is shown as well as the general architecture of the fungal
cell wall, consisting of overlapping layers of highly mannosylated proteins, beta glucans (structure within the insert to the right) and chitin. Antigen
presenting cells (APCs), including monocytes, macrophages and DCs, engage fungi and activate host responses via several PRRs including the Toll-
like receptors (TLR) and Dectin-1. Dectin-1 is alternatively spliced into two functional isoforms, which differ by the presence or absence of a stalk
region (shown in dark blue). Dectin-1 recognises linear or branched 1,3-linked b-glucan, which triggers intracellular signalling through at least two
pathways, involving Syk kinase and Raf-1, inducing the production of several cytokines, including IL-10, TNF, IL-2, IL-6 and IL-23. TLRs, on the
contrary, which recognise various mannosylated and other fungal cell wall structures, signal through the MyD88-Mal mediated NF-kB pathway and
induce the production of both pro and anti-inflammatory cytokines, including TNF, IL-10, IL-12 and TGFb. Co-stimulation of both receptors can amplify
the production of cytokines, including TNF, IL-23, IL-10 and IL-6 while downregulating the production IL-12, influencing the resultant generation of
adaptive immunity.
www.sciencedirect.com Current Opinion in Immunology 2009, 21:30–37
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Dectin-1
Dectin-1 was the first PRR outside of the TLR family
that was found to be capable of inducing its own intra-
cellular signals (Figure 1) [2]. Signalling from this re-
ceptor following ligand binding is mediated through the
cytoplasmic ITAM-like motif that becomes phosphory-
lated by Src family kinases, providing a docking site for
spleen tyrosine kinase (Syk). Despite involving both SH2
domains of Syk, only the membrane proximal tyrosine
(YxxxI/Lx7YxxL) of Dectin-1 was found to be required for
signalling [8,9]. This coupling was unexpected, and its
discovery provided an important breakthrough in our
understanding of activation signalling through single
tyrosine-based motifs. Although the exact mechanism
of signalling is still not fully understood, it has sub-
sequently been shown to be utilised by at least two other
receptors, CLEC9A and CLEC2 [10].
For Dectin-1, like most other myeloid expressed acti-
vation receptors, Syk is a pivotal kinase mediating many
of the receptor’s downstream cellular responses, such as
cytokine production and induction of the respiratory burst
[2]. While the components of the signalling pathway have
yet to be fully elucidated, caspase recruitment domain 9
(CARD9), which assembles with BCL10 and MALT1,
has been identified as an essential downstream adaptor
linking Syk-coupled receptors to the canonical NF-kB
pathway [11,12]. Dectin-1 can also induce the non-cano-
nical NF-kB pathway, being the first PRR shown to do so
[13], and can activate NFAT, implicating these tran-
scription factors in innate antimicrobial immunity,
although the involvement of Syk in this response has
not been established [14]. There is also evidence of Syk-
dependent, but CARD9-independent, pathways, such as
those leading to the induction of ERK, a MAP kinase
regulating the Dectin-1-mediated production of cyto-
kines, particularly IL-10 and IL-2 [15,16].
Dectin-1 can also induce intracellular signalling through
Syk-independent pathways. Phagocytosis in macro-
phages, for example, does not require Syk, although this
response still involves the ITAM-like motif of the re-
ceptor [2]. These pathways are still largely uncharac-
terised, but Dectin-1 was recently found to induce a
Syk-independent pathway involving the serine–threo-
nine kinase Raf-1 [13]. This pathway was shown to
integrate with the Syk pathway, at the level of NF-kB,
and to be involved in controlling Dectin-1 mediated
cytokine production.
Recent trend 2: Interactions between Dectin-1
and other PRRs
The contact of intact pathogens with the host involves
multiple PAMPs and their cognate PRRs, and it is the
complex interaction of the responses mediated by these
receptors, which directs the resultant innate response andCurrent Opinion in Immunology 2009, 21:30–37ultimately the development of pathogen-specific immu-
nity [17]. While our understanding of these receptor
interactions is still in its infancy, the study of host–fungal
interactions has arguably provided one of the best models
in which to study these processes [18]. In addition to
b-glucan, the fungal cell wall possesses other PAMPS
(Figure 1) that are recognised by several PRRs, and
cooperative recognition by these receptors is required
for optimal innate anti-fungal responses [19]. Intrigu-
ingly, recognition by some of these receptors was also
found to occur at different stages during fungal uptake
and phagosomal maturation [20]. The location of PRRs
in different intracellular compartments and the sequen-
tial sampling during microbial uptake, which has also
been described for MyD88 versus TRIF signalling
through TLR4 [21], may therefore be another means
of tailoring innate responses to specific pathogens.
The interactions of Dectin-1 with other receptors, in
particular, have provided some key new insights. In
macrophages, cooperative signalling from both Dectin-
1 and TLR-2 was shown to be required for the induction
of TNF in response to fungi and was the first demon-
stration of such interactions between TLR and non-TLR
receptors [2]. Although Dectin-1 displays a cell-type-
specific ability to directly induce cytokine production,
as described above, in bothmacrophages andDC,Dectin-
1 can interact with other MyD88-coupled TLRs (TLR-2,
TLR-4, TLR-5, TLR7, TLR-9), resulting in the syner-
gistic induction of multiple cytokines including TNF, IL-
10, IL-6 and IL-23 [4,22] (GD Brown et al., unpublished
data). Interestingly, these interactions also result in the
downregulation of IL-12 [23] (GD Brown et al., unpub-
lished data), and the reciprocal regulation of IL-23 and
IL-12 is likely to contribute to the development of
Dectin-1 mediated Th17 responses (see below). How
signalling from these receptors is integrated is unknown,
but requires both the Syk and Raf-1 Dectin-1 mediated
signalling pathways [4,13], and may involve physical
interactions at the plasma or phagosomal membrane
[2,24].
In addition to the TLRs, Dectin-1 can also interact with
several other plasma membrane proteins. In murine
macrophages, Dectin-1 has been shown to cooperate with
SIGNR1 for fungal-binding [25], and in human dendritic
cells, the co-stimulation of DC-SIGN and Dectin-1
induces the metabolism of arachidonic acid [26]. Dec-
tin-1 has also been shown to associate with the ubiquitous
tetraspanin CD63 [27] as well as the immune cell-specific
tetraspanin CD37, an interaction that is thought to
stabilise Dectin-1 at the plasma membrane and be
involved in regulating Dectin-1 mediated IL-6 pro-
duction [28]. These interactions raise the possibility that
Dectin-1 forms part of a tetraspanin mediated supramo-
lecular signalling complex at the cell surface, which may
involve several different PRRs.www.sciencedirect.com
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immunity
An important recent discovery is the ability of Dectin-1 to
induce adaptive immunity. Stimulation of the Dectin-1
pathway inDC using highly purified b-glucans was shown
to be able to induce the differentiation of Th17 and Th1Figure 2
Dectin-1 expressing cells are positioned at portals of pathogen entry and si
skin and palate (arrowheads) but not on the Langerhans cells. Dectin-1 is also
villi and Peyer’s patches (arrowhead). In lymphoid tissues, Dectin-1+ cells a
lymph node) and T cell regions around the central arteriole (small arrowhead
tissues (O-NALT) demonstrate regional similarities to the lymph node. In the
junctional regions. E: epidermis; D: dermis; PP: Peyers’ patch; B: B cell are
www.sciencedirect.comCD4+ T cells both in vitro and in vivo, and importantly
these responses were independent of the TLR signalling
pathways [5]. Similar responses were also observed
during fungal infections in vivo, and in humans [29].
Activation of DC with specific Dectin-1 agonists can
drive the conversion of selected populations of Treg cellstes of T cell development. Dectin-1 is expressed in the dermal layers of
expressed on lung APCs and in the gut, Dectin-1+ cells are located in the
re found in all areas including the germinal centres (small arrowhead in
) in the splenic white pulp. The organised nasal associated lymphoid
thymus, Dectin-1+ cells appear concentrated at the corticomedullary
a; T: T cell area; GC: germinal centre; C: cortex; M: medulla.
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34 Innate immunityinto IL-17 producing T cells [30], although Dectin-1/
TLR costimulationmay rather favour the development of
Treg cells [16,31]. Why Dectin-1 actually promotes Th17
responses, in particular, is unclear, as these responses are
thought to be detrimental during fungal infections [32],
although this is still somewhat controversial [33,34].
However, Dectin-1 may ultimately prove to play a central
role in setting the balance between pro-inflammatory and
anti-inflammatory responses during fungal infections (see
below).
Stimulation of Dectin-1 can also drive CD8+ T cell
responses, and purified b-glucan was found to act as a
potent adjuvant for CTL cross-priming in vivo, eliciting
cytotoxic responses that could protect mice from exper-
imental tumour challenge [35]. In addition, agonists of
Dectin-1 could promote antibody responses in vivo [5].
These data therefore show that stimulation via Dectin-1
can drive all arms of the adaptive immune response,
suggesting that this receptor may be an appropriate
immunotherapeutic target [36].
The capacity of Dectin-1 to drive adaptive immune
responses is thought to stem from its ability to induce
DC maturation and the production of cytokines, such as
IL-6andIL-23 [5].However, these responsesmayalsobe
influenced by the ability of the receptor to interact directly
with lymphocytes. Dectin-1 was originally identified as aFigure 3
Diagrammatic representation of the role of Dectin-1 in anti-Candida immunity
on phagocytes (monocytes, macrophages, dendritic cells and neutrophils) re
early inflammatory cytokines and chemokines. This results in cellular activatio
the development of adaptive immunity, including CD4+ and CD8+ T cell res
Dectin-1, result in susceptibility to systemic and mucosal candidiasis. In hu
deficient in Dectin-1 only show defects in cytokine responses, suggesting th
fungal uptake and killing. The differences in the use of Dectin-1 presumably e
that is observed in humans with defects in this receptor.
Current Opinion in Immunology 2009, 21:30–37receptor for an unidentified endogenous ligand in T cells,
and may function as a co-stimulatory molecule on APCs.
Dectin-1 is also expressed in the medullary and cortico-
medullary regions of the thymus (Figure 2) and could have
some influence on T cell development [2]; however, no
abnormalities in T cell responses or cellular subsets have
been observed in Dectin-1 deficient animals [37,38].
The responses mediated by Dectin-1 may also be
involved in driving autoimmunity. Ligands of this re-
ceptor have been shown to induce autoimmune arthritis
in SKG mice, and antibody-mediated inhibition of Dec-
tin-1 could prevent the development of this disease [39].
Similarly, blockage of Dectin-1 could prevent experimen-
tal autoimmune uveoretinitis, a Th1/Th17 disease
induced by immunisation with retinal antigen in com-
plete Freund’s adjuvant (CFA) (Reid et al., unpublished),
and it is likely that Dectin-1 will be implicated in other
such autoimmune diseases in future. The development of
these diseases may result, at least partly, from the ability
of Dectin-1 to internalise and present endogenous anti-
gens [40].
Recent trend 4: role of Dectin-1 in
anti-microbial immunity
b-Glucans are signature molecules for over a million
fungal species and the identification of Dectin-1 as a
receptor for these carbohydrates, and its expression inin mouse versus man. In mouse, sensing of Candia albicans by Dectin-1
sults in the ingestion and killing of these organisms, and the induction of
n and recruitment of immune cells to the site of infection, and stimulates
ponses. In mice, defects in these responses, caused by deficiency of
mans, Dectin-1 appears to function similarly; however, phagocytes
at other receptors, such as the mannose receptor, are responsible for
xplain the susceptibility to mucocutaneous, but not systemic, candidiasis
www.sciencedirect.com
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(Figure 2), immediately suggested a role in anti-fungal
immunity. Indeed, Dectin-1 has been shown to mediate
the recognition of several important fungal pathogens in
vitro, including Candida, Aspergillus, Pneumocystis and
Coccidioides species [3]. The exact role of Dectin-1 in vivo
is still controversial, but there is strong evidence impli-
cating this receptor in the control of infections with C.
albicans, P. carinii and A. fumigatus [11,37,38,41]. These
studies suggested that murine Dectin-1 is required for
fungal uptake and killing and the induction of early
inflammatory responses, data which clearly correlate with
the in vitro functions described for this receptor
(Figure 3). Also supporting a role for Dectin-1 is the
ability of fungal pathogens to actively mask their b-glucan
to avoid immune recognition, findings that have
prompted interest in drugs that enhance the exposure
of these carbohydrates [42–45].
A polymorphism in human Dectin-1 has been identified
that is associated with an increased risk of mucocutaneous
candidiasis (MG Netea et al., unpublished). Individuals
homozygous for this polymorphism that generates an
early stop codon in the CTLD of Dectin-1, lack expres-
sion of this receptor on the surface of their myeloid cells,
and consequently these cells do not respond to b-glucans.
Importantly these cells also show significant defects in the
production of inflammatory cytokines in response to
intact fungal organisms; however, the uptake and killing
of these organisms is unaffected, indicating that alterna-
tive receptor pathways can mediate these activities. The
functional differences to the murine system presumably
explain the susceptibility of these individuals to muco-
cutaneous, but not systemic, fungal infections (Figure 3).
Studies from three independent laboratories have also
implicated Dectin-1 in the recognition of mycobacteria.
Interestingly, mycobacteria do not express b-glucans and
ligand(s) interacting with Dectin-1 have not been ident-
ified. In vitro studies have suggested that Dectin-1, prob-
ably in collaboration with TLR2, is involved in the
induction of cytokines, including IL-12, in response to
these organisms and may play a role in mycobacterial
phagocytosis [24,46,47].
Summary and future directions
The study of Dectin-1 has provided substantial insights
into the functioning of innate immunity and the devel-
opment of adaptive immune responses. The underlying
signalling pathways used by this receptor, and the effects
of interactions with other receptors, are now starting to be
unravelled, but there are still many gaps, particularly with
regard to interactions between the Dectin-1 and the TLR
pathways. Although accumulating data are pointing in the
direction of Dectin-1 and its agonists as a potential way
forward for adjuvant and immunotherapy development,
further dissection of the complex relationships with otherwww.sciencedirect.comPRRs will facilitate improvements in current therapeutic
and vaccination regimes.
Recent studies using receptor deficient mice and other
murinemodels have demonstrated the importance of this
receptor in anti-fungal immunity; studies that have been
validated by the discovery of polymorphisms of human
Dectin-1 that influence the susceptibility to fungal infec-
tions. Given the significant worldwide burden of candi-
diasis, more experimentation is required to better
understand the role of Dectin-1 in these diseases. Sim-
ilarly, the emerging role of Dectin-1 in anti-mycobacter-
ial immunity and in autoimmunity warrants greater
attention.
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